IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $481,000 | +17.3% | 24,747 | +0.6% | 0.00% | – |
| Q4 2017 | $410,000 | -17.8% | 24,604 | 0.0% | 0.00% | – |
| Q3 2017 | $499,000 | -5.8% | 24,604 | -25.2% | 0.00% | – |
| Q2 2017 | $530,000 | +13.2% | 32,904 | -11.2% | 0.00% | – |
| Q1 2017 | $468,000 | +45.3% | 37,034 | +52.6% | 0.00% | – |
| Q4 2016 | $322,000 | -43.0% | 24,270 | +1.8% | 0.00% | – |
| Q3 2016 | $565,000 | -2.2% | 23,850 | +19.0% | 0.00% | – |
| Q2 2016 | $578,000 | -10.0% | 20,040 | 0.0% | 0.00% | – |
| Q1 2016 | $642,000 | -23.3% | 20,040 | +2.3% | 0.00% | – |
| Q4 2015 | $837,000 | +32.9% | 19,580 | +9.4% | 0.00% | – |
| Q3 2015 | $630,000 | -23.4% | 17,900 | 0.0% | 0.00% | – |
| Q2 2015 | $822,000 | +9.6% | 17,900 | +11.9% | 0.00% | – |
| Q1 2015 | $750,000 | +29.3% | 16,000 | -12.6% | 0.00% | – |
| Q4 2014 | $580,000 | +33.6% | 18,300 | 0.0% | 0.00% | – |
| Q3 2014 | $434,000 | -20.9% | 18,300 | 0.0% | 0.00% | – |
| Q2 2014 | $549,000 | +13.7% | 18,300 | 0.0% | 0.00% | – |
| Q1 2014 | $483,000 | -33.8% | 18,300 | -36.9% | 0.00% | – |
| Q4 2013 | $730,000 | +102.2% | 29,000 | +64.8% | 0.00% | – |
| Q3 2013 | $361,000 | -48.6% | 17,600 | -50.0% | 0.00% | – |
| Q2 2013 | $702,000 | – | 35,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 730,817 | $21,062,000 | 7.59% |
| Hound Partners | 6,757,558 | $194,753,000 | 5.18% |
| Aravt Global | 2,232,500 | $64,341,000 | 4.78% |
| Asymmetry Capital Management, L.P. | 70,235 | $2,024,000 | 3.71% |
| UNIVERSITY OF NOTRE DAME DU LAC | 66,091 | $1,905,000 | 1.80% |
| Orbimed Advisors | 5,886,700 | $169,655,000 | 1.77% |
| Pennant Capital Management, LLC | 1,949,569 | $56,187,000 | 1.44% |
| SECTOR GAMMA AS | 233,934 | $6,742,000 | 1.28% |
| Tygh Capital Management, Inc. | 137,190 | $3,954,000 | 1.11% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 555,086 | $15,998,000 | 0.93% |